Donate

Media center

At PATH, our global health experts are developing partnerships, new devices, and solutions to the world's most pressing health needs. Contact us to speak with one of PATH's experts today.

Contact Us

Senior Director of Marketing & Communications:
Lauren Grella

Email: media@path.org

PATH is advancing health equity around the world

June 7, 2024
Medical oxygen in the spotlight: What can be done to improve access for good?
May 30, 2024
A day with co-creators exhibiting inclusive innovation in Kenya
May 29, 2024
Lessons from Malawi's collaborative approach to digital health

Stay informed with PATH Insights

Featured Press Coverage

April 18, 2024
Millions of Girls in Africa Will Miss HPV Shots After Merck Production Problem
The New York Times
February 8, 2024
Good intentions, bad outcomes: The dangers of donated medical devices
Devex
February 12, 2024
Could new vaccines end malaria in Africa?
Al Jazeera

Recent Press Coverage

  1. Africa’s Current and Planned Vaccine Manufacturing Capacity
    The Africa Centres for Disease Control and Prevention, the Clinton Health Access Initiative, and PATH examined the current and planned vaccine manufacturing capacity in Africa.
    Published: October 2023
  2. A new vaccine will change the balance of the fight against meningitis
    The novel meningococcal conjugate vaccine, Men5CV, developed by the Serum Institute of India and PATH, is expected to be more affordable and accessible to meningitis belt countries.
    Published: October 2023
  3. AstraZeneca committed to tackling CVD across Africa
    PATH’s Dr. Robert Yeboah spoke with B&FT Online about how the AstraZeneca’s Health Hearts Africa (HHA) program people living with hypertension, diabetes, cardiovascular diseases, and noncommunicable diseases in Ghana.
    Published: October 2023
  4. African vaccine manufacturing capacity
    The Africa Centres for Disease Control and Prevention (Africa CDC), the Clinton Health Access Initiative, and PATH have released a new briefing paper, Current and Planned Vaccine Manufacturing in Africa, which assesses vaccine manufacturing capacity.
    Published: October 2023
Previous
Next

We develop evidence-based expertise and resources

Our global team leverages data and evidence to develop resources and innovations that bring good health to more people.

Explore our evidence

Join the latest discussions on health equity.

We partner with the public and private sector, government, and academia from around the world to share insightful conversations on the latest topics affecting health equity.

Explore PATH events

PATH Newsroom

Related articles

Read our latest

948 Item s
948 Item s
    Date
    From
    To
  1. Africa’s medicines regulation gains momentum with landmark Green Book listings
    PATH applauds AUDA-NEPAD and AMRH on the launch of the AMRH Green Book, a significant step forward in strengthening Africa’s regulatory systems.
    Published: April 2025
    Statement
  2. PATH Kenya and partners launch Mother-Baby Friendly Initiative Plus
    MBFI+ is a comprehensive care model to optimize feeding and save lives of SSNBs. This systems strengthening approach links kangaroo mother care, nurturing care, psychosocial support, specialized lactation support, locally appropriate human milk banking, and prevention and treatment of malnutrition as a packaged holistic intervention for mother and baby.
    Published: April 2025
    Press Release
  3. Boosting advanced-stage clinical trial capacity in East and Central Africa to combat regional epidemic threats
    The CEPI-backed Research Preparedness Program in East and Central Africa aims to bolster regional clinical trial capacity and disease outbreak readiness.
    Published: March 2025
    Press Release
  4. PATH's commitment to maternal and newborn health and nutrition at N4G Paris Summit
    Published: March 2025
    Announcement
  5. Bivalent HPV vaccine Cecolin® demonstrates strong safety and immunogenicity in low- and middle-income country populations and in various dosing schedules
    Results from a Phase 3 clinical study of Innovax’s WHO prequalified vaccine can help expand access globally and give countries another option for affordable, sustainable HPV vaccine.
    Published: March 2025
    Announcement
Next